Thermo Fisher Scientific, Inc. (TMO)
699.92
+0.48
(+0.07%)
USD |
NYSE |
Nov 13, 16:00
696.53
-3.39
(-0.48%)
After-Hours: 19:59
Thermo Fisher Scientific Net Income (Quarterly) : 1.727B for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.727B |
| June 30, 2026 | 1.742B |
| March 31, 2026 | 1.656B |
| December 31, 2025 | 1.97B |
| September 30, 2025 | 1.621B |
| June 30, 2025 | 1.619B |
| March 31, 2025 | 1.511B |
| December 31, 2024 | 1.824B |
| September 30, 2024 | 1.63B |
| June 30, 2024 | 1.554B |
| March 31, 2024 | 1.331B |
| December 31, 2023 | 1.606B |
| September 30, 2023 | 1.695B |
| June 30, 2023 | 1.362B |
| March 31, 2023 | 1.292B |
| December 31, 2022 | 1.574B |
| September 30, 2022 | 1.498B |
| June 30, 2022 | 1.668B |
| March 31, 2022 | 2.22B |
| December 31, 2021 | 1.659B |
| September 30, 2021 | 1.902B |
| June 30, 2021 | 1.828B |
| March 31, 2021 | 2.337B |
| December 31, 2020 | 2.499B |
| September 30, 2020 | 1.933B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.156B |
| March 31, 2020 | 788.00M |
| December 31, 2019 | 1.002B |
| September 30, 2019 | 760.00M |
| June 30, 2019 | 1.119B |
| March 31, 2019 | 815.00M |
| December 31, 2018 | 898.00M |
| September 30, 2018 | 709.00M |
| June 30, 2018 | 752.00M |
| March 31, 2018 | 579.00M |
| December 31, 2017 | 530.00M |
| September 30, 2017 | 534.00M |
| June 30, 2017 | 613.00M |
| March 31, 2017 | 551.40M |
| December 31, 2016 | 632.70M |
| September 30, 2016 | 473.50M |
| June 30, 2016 | 516.80M |
| March 31, 2016 | 402.30M |
| December 31, 2015 | 606.30M |
| September 30, 2015 | 477.30M |
| June 30, 2015 | 511.60M |
| March 31, 2015 | 385.10M |
| December 31, 2014 | 604.00M |
| September 30, 2014 | 469.90M |
| June 30, 2014 | 278.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | 458.60M |
| Danaher Corp. | 1.207B |
| Illumina, Inc. | 220.00M |
| Revvity, Inc. | 62.62M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.14B |
| Total Expenses (Quarterly) | 10.42B |
| EPS Diluted (Quarterly) | 4.639 |
| Enterprise Value | 294.59B |
| Gross Profit Margin (Quarterly) | 42.34% |
| Profit Margin (Quarterly) | 14.23% |
| Earnings Yield | 2.71% |
| Operating Earnings Yield | 3.47% |
| Normalized Earnings Yield | 2.756 |